The End of an Era: Optime Care Ceases Korlym Distribution Following Corcept’s Decision to End Exclusive Arrangement
The exclusive distributor for Corcept's drug Korlym quit after the company added a new pharmacy. This minor setback delays plans, but analysts advise buying the stock.